Helping to Detect Blood Cancer Types for Acute Leukemia Patients, Prodia Launches Leukemia Phenotyping Test

JAKARTA, July 19, 2021 – According to data from the Global Burden of Cancer (GLOBOCAN) 2020, Blood Cancer or Leukemia ranks 13th as a contributor to new cancer cases in the world. In Indonesia, Leukemia ranks 9th as a contributor to new cases of cancer. Leukemia is also one of the most common types of cancer in children. In fact, one third of cancer cases in children in Indonesia are leukemia. In 2010, the number of leukemia patients was 31% of the total childhood cancers. This percentage continued to increase to 35% in 2011, 42% in 2012, and 55% in 2013.

The increasing number of Leukemia cases in Indonesia, especially among children, has prompted PT Prodia Widyahusada Tbk (Stock Code: PRDA) to launch a Leukemia Phenotyping test to detect the type of blood cancer in acute leukemia patients. Leukemia Phenotyping is a test recommended by WHO for the diagnosis of Acute Leukemia. Currently, Prodia is the only private clinical laboratory in Indonesia that can independently perform Leukemia Phenotyping  with blood samples.

Product Manager of Prodia Trilis Yulianti said, "The Leukemia Phenotyping test at Prodia can help doctors in establishing patient diagnoses faster, because it is carried out every day with a H+2 result completion time. The accuracy of the diagnosis will greatly affect the treatment and the success rate of healing. We hope to contribute in increasing the life expectancy of people with leukemia,” said Trilis at Prodia Tower, Jakarta (19/7).

Leukemia is a form of blood cancer which consists of several types including Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), and a combination of the two types Mixed Phenotype Acute Leukemia (MPAL) where the incidence of MPAL type leukemia is still low in Indonesia.

Based on data from the Ministry of Health in 2012, of the number of people with leukemia in Indonesia, around 97% are acute leukemia (82% ALL and 18% AML) and 3% chronic leukemia (CML). Leukemia mortality rate at Cipto Mangunkusumo Hospital and Dharmais Cancer Hospital in 2006-2010 was 20-30% for ALL in children. Male sufferers are 1.15 times higher than female for ALL and in AML leukemia males and females are almost the same.

"If people with leukemia have not been tested with a leukemia phenotyping test, then it can't be established whether a person's type of leukemia is b-ALL or T-ALL or AML. For now, Prodia has not provided Leukemia Phenotyping for bone marrow samples. According to NCCN V.1 2021, if there are enough circulating lymphoblasts and the clinical situation does not allow for bone marrow biopsy, then a peripheral blood sample can replace bone marrow aspiration,” added Trilis

Leukemia phenotyping with blood samples has been carried out at the Prodia Immunology Laboratory on Jalan Kramat Raya 150, Central Jakarta since July 2021. Currently, all Prodia branches can perform the Leukemia Phenotyping test and make a test referral to the Prodia Immunology Laboratory.

*****

About PT Prodia Widyahusada Tbk

Prodia Clinical Laboratory was initially established in Solo on 7 May 1973 by a group of idealist pharmacists. From the very first, Andi Wijaya, along with the other founders have been committed to present the best test results with wholehearted services.

As the market leader, since 2012 Prodia has been the only laboratory and clinic in Indonesia accredited by the College of American Pathologists (CAP). It implies that Prodia' s test results are equal in quality to those obtained from other international laboratories.

On 7 December 2016, the Indonesia Stock Exchange officially listed the initial public offering of Prodia as the 15th issuer in 2016, with the ticker symbol 'PRDA'. In that corporate action, Prodia offered 187.5 million shares. Accordingly, the fund raised from the Company' s initial public offering (IPO) was Rp1.22 trillion.

Currently, Prodia has had the service network that incorporates 269 outlets, across 127 cities and 34 provinces in Indonesia, Prodia Health Care (PHC) - a personalized medicine-based wellness clinic - and specialty clinics, including Prodia Children' s Health Centre (PCHC), Prodia Women' s Health Centre (PWHC), and Prodia Senior Health Centre (PSHC).

Prodia has launched Kontak Prodia 1500-830 and the online-based virtual personal assistant Tanya Prodia (TANIA). TANIA can be accessed by anyone, especially Prodia customers directly anytime and anywhere online including via LINE: @prodia.id, Telegram: @prodia.id, Facebook Messenger: @prodia.id and Prodia Website: www.prodia.co.id.

For more information, please visit www.prodia.co.id or contact:  

Marina Eka Amalia   

Legal Head & Corporate Secretary

PT Prodia Widyahusada Tbk. 

Ph.       +62-21-3144182 ext 3816

Email     corporate.secretary@prodia.co.id